about
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipientsTacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipientsLessons learned from more than 1,000 pancreas transplants at a single institutionHistory of clinical transplantationPancreatic islet transplantation after upper abdominal exenteration and liver replacementThe Surgical Approach to Short Bowel Syndrome - Autologous Reconstruction versus TransplantationHepatologyFK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae.Tacrolimus in preventing transplant rejection in Chinese patients--optimizing useEffects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell levelClinical intestinal transplantation: a decade of experience at a single centerReplicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugsInfluence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trialOrthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experienceTacrolimus for the prevention and treatment of rejection of solid organ transplants.The unfinished legacy of liver transplantation: emphasis on immunology.Themes of liver transplantation.FK506 and the role of the immunophilin FKBP-52 in nerve regeneration.Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.Acquired immunologic tolerance: with particular reference to transplantationLiver transplantation: fifty years of experience.Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease.Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles.Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.The effects of FK 506 on renal function after liver transplantation.Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.Early trials with FK 506 as primary treatment in liver transplantationFK 506 dosage in human organ transplantation.Oral glucose tolerance test in liver recipients treated with FK 506.Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients.Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders.''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation.Orthotopic liver transplantation for patients with hepatitis B virus-related liver diseaseEffect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment.
P2860
Q24202759-ECAAF91F-2E00-4FB2-A051-93C630709986Q24236783-89C7AC35-60BA-43BC-96DB-CEDA6CF55CDDQ24541751-3A6C4721-A955-4486-99A8-0C89F23588C6Q24596303-DBDFEC50-5CC2-4BBE-86EC-A56974743402Q24615896-D4C2B645-E344-4431-B9A2-A85BEAD8CFE0Q27015103-C918B685-71CB-45A0-90AF-D22AFA479021Q27486176-67BF1B29-72ED-40EF-AF82-62BB369EE012Q27931207-5C725A90-AFF1-47E3-9D05-D823AC0E005CQ28087131-C00C2F87-6A93-419D-9E84-BCB0A7F24FF0Q28316111-C60BBC8F-D356-4D6F-98B1-151CDA4E1900Q28346861-45808337-508F-4986-8129-D1131310EBC3Q28362068-517704EE-2F7C-4065-9772-687537EE6A21Q28367696-09E725DE-BC93-4376-8553-13A9F37E6378Q28769327-E39CD271-DC62-4353-A962-838284B72387Q30278052-623E07EC-B232-479F-8111-2F5D0A1C3479Q30352760-56155EF3-EA7F-4744-9DA6-2720642F3EA4Q30658256-D9B54600-D5E4-4189-AA39-6616E1EDB2C6Q30759435-5EF7A7E8-1A36-4E51-AA51-56395A420B7CQ33415182-250C672C-4A19-45E3-8725-091EF8C1E486Q33567138-DC3987D9-A995-4F74-9DAE-5478045FD73FQ33594885-2FAA135A-9975-4E5A-A713-E5BDC4B8D949Q33670571-8AEADF6A-16D7-42D8-9C40-86158D2ED327Q33678309-F0EA9E86-33A5-40AA-AF15-62970CE72B8BQ33911404-6BD10F75-00EC-4B64-A368-4CF8A1CA8095Q33930853-554F7C92-B754-469E-AE80-A75A7FA6C85DQ33951385-F722C2AB-1AD6-4EFC-9227-A608BF47723CQ33993486-D4CD1CD9-B35F-4C7A-B47E-3A085AF5943BQ33993513-0B1ECD04-2E8D-4B46-BDCA-07C01C76A2B9Q33993525-E5142768-6A8B-4E9C-8A6D-EB8513865731Q33993541-93CB73BF-E9CD-403C-8AF5-E008FD4618D6Q33993567-F33F896B-4CDA-4979-89D7-C83C57C9FE73Q33993573-A4F91AA7-EB66-4CAC-A30C-2FCB9221071FQ33993577-4EB0599F-397B-43A7-B564-F5612F5E4102Q33999915-D1C92F1D-8ECD-46D5-9E69-773EB73B56D9Q34075121-8C8FF8B6-E329-47D5-8B68-1DC5E0FB71F7Q34093895-1D7954A2-D442-47E6-8118-104D2031E821Q34094783-59BF678C-E03F-416C-9A6E-E58F2208033EQ34146704-6F6FF3EF-74B5-4615-A200-32E49E25061FQ34178467-7297D192-1DD2-4112-8756-67B5B4CC22EBQ34178489-52A9CDEA-D060-43BC-95B1-AAD721E6F805
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
FK 506 for liver, kidney, and pancreas transplantation.
@ast
FK 506 for liver, kidney, and pancreas transplantation.
@en
FK 506 for liver, kidney, and pancreas transplantation.
@nl
type
label
FK 506 for liver, kidney, and pancreas transplantation.
@ast
FK 506 for liver, kidney, and pancreas transplantation.
@en
FK 506 for liver, kidney, and pancreas transplantation.
@nl
prefLabel
FK 506 for liver, kidney, and pancreas transplantation.
@ast
FK 506 for liver, kidney, and pancreas transplantation.
@en
FK 506 for liver, kidney, and pancreas transplantation.
@nl
P2093
P2860
P50
P1433
P1476
FK 506 for liver, kidney, and pancreas transplantation.
@en
P2093
P2860
P304
P356
10.1016/S0140-6736(89)91014-3
P407
P577
1989-10-01T00:00:00Z